Interestingly, a previous study showed that NHERF1 with a mutation in the PDZ2 domain changes its localization in breast cancer [53]; since we have not observed a similar phenotype with NHERF2, this indicates that modifications in NHERF2 might have exclusive roles in carcinogenesis. Here, NHERF1 is linked to breast carcinoma.